CHANNELS

Subscribe to the InfoTech eNewsletter

infoTECH News

TMCNet:  Research and Markets: Gaucher's Disease - Pipeline Review, H2 2013 Research Report

[February 05, 2014]

Research and Markets: Gaucher's Disease - Pipeline Review, H2 2013 Research Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/5kpmct/gauchers_disease) has announced the addition of the "Gaucher's Disease - Pipeline Review, H2 2013" report to their offering.

'Gaucher's Disease - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Gaucher's Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gaucher's Disease.

Scope

- A snapshot of the global therapeutic scenario for Gaucher's Disease.

- A review of the Gaucher's Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Gaucher's Disease pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projecs.

- Latest news and deals relating to the products.

Key Topics Covered:

Introduction

Gaucher's Disease Overview

Therapeutics Development

Pipeline Products for Gaucher's Disease - Overview

Pipeline Products for Gaucher's Disease - Comparative Analysis

Gaucher's Disease - Therapeutics under Development by Companies

Gaucher's Disease - Therapeutics under Investigation by Universities/Institutes

Gaucher's Disease - Pipeline Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Unknown Stage Products

Gaucher's Disease - Products under Development by Companies

Gaucher's Disease - Products under Investigation by Universities/Institutes

Gaucher's Disease - Companies Involved in Therapeutics Development

Gaucher's Disease - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target (News - Alert)

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Assessment by Therapeutic Class

Drug Profiles

eliglustat tartrate - Drug Profile

acetylcysteine - Drug Profile

ambroxol - Drug Profile

PRX-112 - Drug Profile

AT-3375 - Drug Profile

JR-101 - Drug Profile

NP-003 - Drug Profile

imiglucerase Biosimilar - Drug Profile

LB-201 - Drug Profile

LB-205 - Drug Profile

Gluco-Cerebosidase - Drug Profile

BNT-001 - Drug Profile

Glucocerebrosidase Activators - Drug Profile

DOS-000011 - Drug Profile

imiglucerase Biosimilar - Drug Profile

Companies Mentioned

Genzyme Corporation

Amicus Therapeutics, Inc.

Lixte Biotechnology Holdings, Inc.

Protalix BioTherapeutics, Inc.

JCR Pharmaceuticals Co., Ltd.

greenovation Biotech GmbH

Neuraltus Pharmaceuticals, Inc.

Biosidus S.A.

ExSAR Corporation

Bioorganic Research and Services S.A.

Dong-A Socio Holdings Co Ltd

For more information visit http://www.researchandmarkets.com/research/5kpmct/gauchers_disease

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ InfoTech Spotlight's Homepage ]


blog comments powered by Disqus

FOLLOW US

Subscribe to InfoTECH Spotlight eNews

InfoTECH Spotlight eNews delivers the latest news impacting technology in the IT industry each week. Sign up to receive FREE breaking news today!
FREE eNewsletter